Fig 1: Inhibition of anti-SLAMF7-mediated ADCC activity against MM cells by rhSLAMF7(A) Dose-dependent inhibition of anti-SLAMF7-mediated ADCC by rhSLAMF7. U266 cells treated with 20 µg/ml of anti-SLAMF7 antibody were co-cultured with NK-92MI cells at an effector : target ratio of 10:1. (B) In the ADCC assay, U266 cells treated with anti-SLAMF7 antibody were mixed with NK-92MI cells at different target : effector cell ratios. The data are expressed as mean ± SD of triplicate experiments. **P<0.01.